Neglected Tropical Diseases

These diseases include lymphatic filariasis, onchocerciasis, and blinding trachoma. The program has grown to support 25 countries in Africa, Asia, and Haiti, as well as six countries in a regional program in the Americas. Since its inception in 2006, the U.S. Congress has appropriated $586 million to the USAID NTD Program. The program has delivered over 1 billion treatments, with a cumulative total of 1.4 billion treatments delivered between 2006-2015. This has resulted in the treatment of approximately 687 million people. The program has also trained 367,000 community drug distributors each year. The USAID NTD Program focuses on country-level platforms that make mass treatment possible. These core investments include disease mapping, drug distribution, and monitoring program impact. In addition to mass treatment, the program recognizes the need for morbidity management and improving services to alleviate the suffering of individuals facing debilitating consequences of NTDs. The program collaborates with a variety of partners, including the United Nations, foundations, non-governmental organizations, faith-based organizations, and the private sector. Generous drug donations from pharmaceutical companies has topped $11.1 billion worth of drugs for NTDs for countries where USAID supports mass treatment campaigns. The program has seen great reductions in the presence of lymphatic filariasis, with 18 countries having achieved significant progress in controlling the disease. The USAID NTD Program has made significant progress in controlling and eliminating NTDs. Eighteen countries have achieved significant reductions in lymphatic filariasis, with 15 countries having similar success in controlling blinding trachoma. The program has also trained community drug distributors to deliver treatments to communities. The USAID NTD Program has made significant investments in disease mapping, drug distribution, and monitoring program impact. The program has also made significant investments in morbidity management and improving services to alleviate the suffering of individuals facing debilitating consequences of NTDs. The USAID NTD Program has collaborated with a variety of partners, including the United Nations, foundations, non-governmental organizations, faith-based organizations, and the private sector. The program has seen significant progress in controlling and eliminating NTDs, with 18 countries having achieved significant reductions in lymphatic filariasis and 15 countries having similar success in controlling blinding trachoma.